Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Aug;24(4):666-674.
doi: 10.1007/s11307-022-01718-0. Epub 2022 Mar 29.

Detection of cardiac apoptosis by [18F]ML-10 in a mouse model of permanent LAD ligation

Affiliations

Detection of cardiac apoptosis by [18F]ML-10 in a mouse model of permanent LAD ligation

Maximilian Fischer et al. Mol Imaging Biol. 2022 Aug.

Abstract

Purpose: The loss of viable cardiac cells and cell death by myocardial infarction (MI) is still a significant obstacle in preventing deteriorating heart failure. Imaging of apoptosis, a defined cascade to cell death, could identify areas at risk.

Procedures: Using 2-(5-[18F]fluoropentyl)-2-methyl-malonic acid ([18F]ML-10) in autoradiography and positron emission tomography (PET) visualized apoptosis in murine hearts after permanent ligation of the left anterior descending artery (LAD) inducing myocardial infarction (MI). 2-deoxy-2-[18F]fluoro-D-glucose ([18F]FDG) PET imaging localized the infarct area after MI. Histology by terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL) staining validated apoptosis in the heart.

Results: Accumulation of [18F]ML-10 was evident in the infarct area after permanent ligation of the LAD in autoradiography and PET imaging. Detection of apoptosis by [18F]ML-10 is in line with the defect visualized by [18F]FDG and the histological approach.

Conclusion: [18F]ML-10 could be a suitable tracer for apoptosis imaging in a mouse model of permanent LAD ligation.

Keywords: Apoptosis; Autoradiography; Cardiac positron emission tomography; Myocardial infarct; [18F]FDG; [18F]ML-10.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no conflict of interest.

Figures

Fig. 1
Fig. 1
Autoradiography of [18F]ML-10 after MI (A) Structure of [18F]ML-10. (B) Schematic study design illustrating the induction of myocardial infarct (MI) by permanent LAD ligation, injection of [18F]ML-10 and [18F]FDG, autoradiography, PET imaging, and histology at different time points. (C) Autoradiographic evaluation of the [18F]ML-10 uptake after MI at different time points. Hearts are illustrated at different sections (apex, mid-ventricular, base). (D) Quantification of the target-to-background ratio (TBR) after different time points. N = 2–3. Data represent mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001
Fig. 2
Fig. 2
[18F]FDG and [18F]ML-10 PET imaging after MI. (A) Representative [18F]FDG image illustrating the MI. Arrows indicate the infarct area of the left ventricle. R right, L left, D dorsal, V ventral. Color scale: Volcano. (B) Representative images of [18F]FDG and [18F]ML-10 after permanent LAD ligation. Arrows indicate infarct area detected by diminished [18F]FDG uptake and evident [18F]ML-10 uptake. Color scale: Ocean. (C) Quantification of the injected dose per gram of [18F]ML-10 after different time points. N = 5–7. Data represent mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001
Fig. 3
Fig. 3
Histological evaluation by TUNEL staining after MI. (A) TUNEL staining of the heart after MI. Right ventricular myocardium (RVM), interventricular septum (IVS), left ventricle LV, left ventricular myocardium (LVM). Bar equals 500 μm. (B) Quantification of TUNEL positive cells in the whole heart after different time points. N = 5–7. (C) Quantification of TUNEL positive cells in the infarct area after different time points. N = 5–7. (D) Quantification of TUNEL positive cells in the remote area after different time points. N = 5–7. Data represent mean ± SEM. * p < 0.05, ** p < 0.01, *** p < 0.001

Similar articles

Cited by

References

    1. Fulda S, Debatin K-M. Extrinsic versus intrinsic apoptosis pathways in anticancer chemotherapy. Oncogene. 2006;25:4798–4811. doi: 10.1038/sj.onc.1209608. - DOI - PubMed
    1. Hengartner MO. The biochemistry of apoptosis. Nature. 2000;407:770–776. doi: 10.1038/35037710. - DOI - PubMed
    1. Gill C, Mestril R, Samali A. Losing heart: the role of apoptosis in heart disease—a novel therapeutic target? FASEB J. 2002;16:135–146. doi: 10.1096/fj.01-0629com. - DOI - PubMed
    1. Riedl SJ, Shi Y. Molecular mechanisms of caspase regulation during apoptosis. Nat Rev Mol Cell Biol. 2004;5:897–907. doi: 10.1038/nrm1496. - DOI - PubMed
    1. Buja LM, Entman ML. Modes of Myocardial Cell Injury and Cell Death in Ischemic Heart Disease. Circulation. 1998;98:1355–1357. doi: 10.1161/01.CIR.98.14.1355. - DOI - PubMed

Publication types

Substances